24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
OrbiMed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:23
Intel shares fall back to April levels after losing over half their value in five weeks
21:50
Intel’s Israeli workers fear another downturn after stock collapse and deadly factory blast
21:37
Ground Up Ventures appoints Navot Volk as General Partner
21:22
After years of delays, IDF prepares to deploy Elbit’s new Ro'em artillery systems
More stories
Buzz
Most popular
Daily
Weekly
1
From six-person startups to a $6.3 billion take-private: October's extraordinary month for Israeli tech exits
2
ServiceNow CEO says acquired Israeli startup Sweep helps it switch CRM customers in weeks, not years
3
Perion to be acquired by India’s Affle for $420 million, marking a steep fall for a once-billion-dollar Israeli company
4
Israeli digital health company TailorMed acquired in $250 million deal
5
Intel’s Israeli workers fear another downturn after stock collapse and deadly factory blast
More news
OrbiMed
4 stories about OrbiMed
OrbiMed chooses against raising a third Israeli healthcare-dedicated fund
07.01.21
|
Meir Orbach
The investment firm raised a $307 million fund in 2016, but will not be founding another in a blow to the local ecosystem
Biological cancer treatment company Novellus raises $57 million
22.09.20
|
Tzally Greenberg
Novellus develops a drug that delays the development of a BRAF gene mutation created in cases of thyroid cancer and glioma cancer
OrbiMed Invests $16 Million in Derma Company Foamix
17.04.18
|
Lilach Baumer
Foamix is a clinical-stage company developing specialty foam-based treatments for skin conditions such as acne
Peter Thiel Invests in Israeli Biopharmaceutical Startup ChemomAb
04.12.17
|
Meir Orbach
ChemomAb develops an antibody treatment for inflammatory and fibrotic diseases